<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02716298</url>
  </required_header>
  <id_info>
    <org_study_id>EX-MKTG-64</org_study_id>
    <nct_id>NCT02716298</nct_id>
  </id_info>
  <brief_title>A Dispensing Clinical of Fanfilcon A Lens Against Lotrafilcon B Lens Over 1 Month Wear Per Lens</brief_title>
  <official_title>A Dispensing Clinical of Fanfilcon A Lens Against Lotrafilcon B Lens Over 1 Month Wear Per Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study to evaluate the performance of fanfilcon A lens when worn on a daily wear
      modality over approximately 1 month in comparison to the lotrafilcon B lens.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a 45 subject, 1-month dispensing, crossover, double-masked, randomized, bilateral
      study comparing the test lens against the control lens. Both test and control lenses will be
      used in a daily wear modality for 1 month each.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subjective Comfort</measure>
    <time_frame>Baseline, 1 month</time_frame>
    <description>Subjective ratings on comfort at insertion (at baseline), comfort when lenses are first put in, comfort during the day's wear, and comfort prior to lens removal (1 month) for fanfilcon A and lotrafilcon B lens. (Scale 0-10, 10=Can't feel the lenses, 0=Painful).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective Preference</measure>
    <time_frame>1 month</time_frame>
    <description>Subjective ratings on preference for fanfilcon A and lotrafilcon B lens. (Strongly prefer fanfilcon A, slightly prefer fanfilcon A, no preference, slightly prefer lotrafilcon B, strongly prefer lotrafilcon B).
Subject preference in terms of comfort, dryness, clear vision, Lens Handling, digital devices, all day natural comfort, All day comfort, same comfort at the end of the day (EOD), comfortable after the end of 4 weeks, Same comfort at 4 weeks as initial, comfortable in dry environments, help focus effortlessly while using digital devices, help with end of day (EOD) dryness, help eyes feel less tired at EOD (including computer or digital device use), offering clear vision during driving.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lens Wettability</measure>
    <time_frame>Baseline, 1 month</time_frame>
    <description>Lens wettability for fanfilcon A and lotrafilcon B lens. (Scale 0-4, 0.25 steps, 0=excellent, 4=severely reduced)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Surface Deposits</measure>
    <time_frame>Baseline, 1 month</time_frame>
    <description>Surface deposits for fanfilcon A and lotrafilcon B lens. (Scale 0-4, 0.25 steps, 0=excellent, 4=severely reduced)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">49</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>fanfilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Study participants are randomized to wear fanfilcon A lens during the crossover study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lotrafilcon B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Study participants are randomized to wear lotrafilcon B lens during the crossover study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>fanfilcon A</intervention_name>
    <description>contact lens</description>
    <arm_group_label>fanfilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>lotrafilcon B</intervention_name>
    <description>contact lens</description>
    <arm_group_label>lotrafilcon B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        A person is eligible for inclusion in the study if he/she:

          -  Is at least 17 years of age and has full legal capacity to volunteer;

          -  Has read and signed an information consent letter;

          -  Is willing and able to follow instructions and maintain the appointment schedule;

          -  Is correctable to a visual acuity of 20/30 or better (in each eye) with their habitual
             correction and the assigned study lenses;

          -  Is an adapted soft contact lens wearer (For the purpose of this study: Current lens
             wear at least 3 days per week, 8 hours each day);

          -  Demonstrates an acceptable fit with the study lenses.

        Exclusion Criteria:

        A person will be excluded from the study if he/she:

          -  Is participating in any concurrent clinical or research study;

          -  Is a habitual wearer of lotrafilcon B or enfilcon A lenses.

          -  Has any known active* ocular disease and/or infection;

          -  Has a systemic condition that in the opinion of the investigator may affect a study
             outcome variable;

          -  Is using any systemic or topical medications that in the opinion of the investigator
             may affect a study outcome variable;

          -  Has known sensitivity to the diagnostic pharmaceuticals to be used in the study;

          -  Is pregnant, lactating or planning a pregnancy at the time of enrollment; (by verbal
             confirmation at the Screening Visit)

          -  Is aphakic;

          -  Has undergone refractive error surgery;

               -  For the purposes of this study, active ocular disease is defined as infection or
                  inflammation which requires therapeutic treatment. Mild (i.e. not considered
                  clinically relevant) lid abnormalities (blepharitis, meibomian gland dysfunction,
                  papillae), corneal and conjunctival staining and dry eye are not considered
                  active ocular disease. Neovascularization and corneal scars are the result of
                  previous hypoxia, infection or inflammation and are therefore not active.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lyndon Jones</last_name>
    <role>Principal Investigator</role>
    <affiliation>Director, Centre for Contact Lens Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Center for Contact Lens Research, University of Waterloo</name>
      <address>
        <city>Waterloo</city>
        <state>Ontario</state>
        <zip>N2L 3G1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2016</study_first_submitted>
  <study_first_submitted_qc>March 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 23, 2016</study_first_posted>
  <results_first_submitted>January 30, 2017</results_first_submitted>
  <results_first_submitted_qc>January 30, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">March 21, 2017</results_first_posted>
  <last_update_submitted>April 25, 2017</last_update_submitted>
  <last_update_submitted_qc>April 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Fanfilcon A Then Lotrafilcon B</title>
          <description>Study participants are randomized to wear fanfilcon A lens for 1 month, then lotrafilcon B for 1 month during the crossover study
fanfilcon A: contact lens lotrafilcon B: contact lens</description>
        </group>
        <group group_id="P2">
          <title>Lotrafilcon B Then Fanfilcon A</title>
          <description>Study participants are randomized to wear lotrafilcon B for 1 month, then fanfilcon A lens for 1 month during the crossover study.
lotrafilcon B: contact lens fanfilcon A: contact lens</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention (1 Month)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lens discomfort</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Second Intervention (1 Month)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Overall Participants</title>
          <description>Study participants are randomized to wear fanfilcon A lens or lotrafilcon B lens for 1 month during the crossover study
fanfilcon A: contact lens lotrafilcon B: contact lens</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="49"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.1" lower_limit="18" upper_limit="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Subjective Comfort</title>
        <description>Subjective ratings on comfort at insertion (at baseline), comfort when lenses are first put in, comfort during the day's wear, and comfort prior to lens removal (1 month) for fanfilcon A and lotrafilcon B lens. (Scale 0-10, 10=Can't feel the lenses, 0=Painful).</description>
        <time_frame>Baseline, 1 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fanfilcon A</title>
            <description>Study participants are randomized to wear fanfilcon A lens for 1 month during the crossover study
fanfilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Lotrafilcon B</title>
            <description>Study participants are randomized to wear lotrafilcon B lens for 1 month during the crossover study.
lotrafilcon B: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Comfort</title>
          <description>Subjective ratings on comfort at insertion (at baseline), comfort when lenses are first put in, comfort during the day's wear, and comfort prior to lens removal (1 month) for fanfilcon A and lotrafilcon B lens. (Scale 0-10, 10=Can't feel the lenses, 0=Painful).</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline - Comfort at Insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" spread="0.93"/>
                    <measurement group_id="O2" value="9" spread="1.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Month - Comfort when lenses are first put in</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" spread="1.26"/>
                    <measurement group_id="O2" value="9" spread="1.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Month - Comfort during the day's wear</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" spread="1.32"/>
                    <measurement group_id="O2" value="8" spread="1.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Month - Comfort just prior to lens removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" spread="1.78"/>
                    <measurement group_id="O2" value="7" spread="2.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subjective Preference</title>
        <description>Subjective ratings on preference for fanfilcon A and lotrafilcon B lens. (Strongly prefer fanfilcon A, slightly prefer fanfilcon A, no preference, slightly prefer lotrafilcon B, strongly prefer lotrafilcon B).
Subject preference in terms of comfort, dryness, clear vision, Lens Handling, digital devices, all day natural comfort, All day comfort, same comfort at the end of the day (EOD), comfortable after the end of 4 weeks, Same comfort at 4 weeks as initial, comfortable in dry environments, help focus effortlessly while using digital devices, help with end of day (EOD) dryness, help eyes feel less tired at EOD (including computer or digital device use), offering clear vision during driving.</description>
        <time_frame>1 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Strongly Prefer Fanfilcon A</title>
            <description>Study participants are randomized to wear fanfilcon A lens for 1 month during the crossover study
fanfilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Slightly Prefer Fanfilcon A</title>
            <description>Study participants are randomized to wear fanfilcon A lens for 1 month during the crossover study
fanfilcon A: contact lens</description>
          </group>
          <group group_id="O3">
            <title>No Preference</title>
          </group>
          <group group_id="O4">
            <title>Slightly Prefer Lotrafilcon B</title>
            <description>Study participants are randomized to wear lotrafilcon B lens for 1 month during the crossover study
lotrafilcon B: contact lens</description>
          </group>
          <group group_id="O5">
            <title>Strongly Prefer Lotrafilcon B</title>
            <description>Study participants are randomized to wear lotrafilcon B lens for 1 month during the crossover study
lotrafilcon B: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Preference</title>
          <description>Subjective ratings on preference for fanfilcon A and lotrafilcon B lens. (Strongly prefer fanfilcon A, slightly prefer fanfilcon A, no preference, slightly prefer lotrafilcon B, strongly prefer lotrafilcon B).
Subject preference in terms of comfort, dryness, clear vision, Lens Handling, digital devices, all day natural comfort, All day comfort, same comfort at the end of the day (EOD), comfortable after the end of 4 weeks, Same comfort at 4 weeks as initial, comfortable in dry environments, help focus effortlessly while using digital devices, help with end of day (EOD) dryness, help eyes feel less tired at EOD (including computer or digital device use), offering clear vision during driving.</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="47"/>
                <count group_id="O3" value="47"/>
                <count group_id="O4" value="47"/>
                <count group_id="O5" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="16"/>
                    <measurement group_id="O5" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dryness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="14"/>
                    <measurement group_id="O5" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clear vision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.64"/>
                    <measurement group_id="O2" value="25.0"/>
                    <measurement group_id="O3" value="29.55"/>
                    <measurement group_id="O4" value="4.55"/>
                    <measurement group_id="O5" value="2.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lens Handling</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="52"/>
                    <measurement group_id="O4" value="23"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Digital devices</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.27"/>
                    <measurement group_id="O2" value="27.27"/>
                    <measurement group_id="O3" value="40.91"/>
                    <measurement group_id="O4" value="2.27"/>
                    <measurement group_id="O5" value="2.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All day natural comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="14"/>
                    <measurement group_id="O5" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All day comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                    <measurement group_id="O2" value="39"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="18"/>
                    <measurement group_id="O5" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Same comfort at EOD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="25"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="14"/>
                    <measurement group_id="O5" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Comfortable after the end of 4 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="20"/>
                    <measurement group_id="O5" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Same comfort at 4 weeks as initial</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="25"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="14"/>
                    <measurement group_id="O5" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Comfortable in dry environments</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.64"/>
                    <measurement group_id="O2" value="15.91"/>
                    <measurement group_id="O3" value="29.55"/>
                    <measurement group_id="O4" value="4.55"/>
                    <measurement group_id="O5" value="11.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Help focus effortlessly while using digital device</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.55"/>
                    <measurement group_id="O2" value="27.27"/>
                    <measurement group_id="O3" value="34.09"/>
                    <measurement group_id="O4" value="4.55"/>
                    <measurement group_id="O5" value="4.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Help with EOD dryness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="25"/>
                    <measurement group_id="O3" value="23"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Help eyes feel less tired at EOD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.36"/>
                    <measurement group_id="O2" value="18.18"/>
                    <measurement group_id="O3" value="31.82"/>
                    <measurement group_id="O4" value="11.36"/>
                    <measurement group_id="O5" value="2.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Offering clear vision during driving.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="29"/>
                    <measurement group_id="O3" value="26"/>
                    <measurement group_id="O4" value="11"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Lens Wettability</title>
        <description>Lens wettability for fanfilcon A and lotrafilcon B lens. (Scale 0-4, 0.25 steps, 0=excellent, 4=severely reduced)</description>
        <time_frame>Baseline, 1 month</time_frame>
        <population>One participant excluded from analysis at 1 month.</population>
        <group_list>
          <group group_id="O1">
            <title>Fanfilcon A</title>
            <description>Study participants are randomized to wear fanfilcon A lens for 1 month during the crossover study
fanfilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Lotrafilcon B</title>
            <description>Study participants are randomized to wear lotrafilcon B lens for 1 month during the crossover study.
lotrafilcon B: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Lens Wettability</title>
          <description>Lens wettability for fanfilcon A and lotrafilcon B lens. (Scale 0-4, 0.25 steps, 0=excellent, 4=severely reduced)</description>
          <population>One participant excluded from analysis at 1 month.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="47"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.76" spread="0.61"/>
                    <measurement group_id="O2" value="0.56" spread="0.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 month</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.85" spread="0.71"/>
                    <measurement group_id="O2" value="1.08" spread="0.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Surface Deposits</title>
        <description>Surface deposits for fanfilcon A and lotrafilcon B lens. (Scale 0-4, 0.25 steps, 0=excellent, 4=severely reduced)</description>
        <time_frame>Baseline, 1 month</time_frame>
        <population>One participant excluded from analysis at 1 month.</population>
        <group_list>
          <group group_id="O1">
            <title>Fanfilcon A</title>
            <description>Study participants are randomized to wear fanfilcon A lens for 1 month during the crossover study
fanfilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Lotrafilcon B</title>
            <description>Study participants are randomized to wear lotrafilcon B lens for 1 month during the crossover study.
lotrafilcon B: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Surface Deposits</title>
          <description>Surface deposits for fanfilcon A and lotrafilcon B lens. (Scale 0-4, 0.25 steps, 0=excellent, 4=severely reduced)</description>
          <population>One participant excluded from analysis at 1 month.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="47"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.22"/>
                    <measurement group_id="O2" value="0.26" spread="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Month</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.34" spread="0.45"/>
                    <measurement group_id="O2" value="0.41" spread="0.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Fanfilcon A</title>
          <description>Study participants are randomized to wear fanfilcon A lens during the crossover study
fanfilcon A: contact lens</description>
        </group>
        <group group_id="E2">
          <title>Lotrafilcon B</title>
          <description>Study participants are randomized to wear lotrafilcon B lens during the crossover study.
lotrafilcon B: contact lens</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Senior Manager Global Medical Scientific Affairs</name_or_title>
      <organization>CooperVision</organization>
      <phone>925-621-3761</phone>
      <email>javega@coopervision.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

